FDA Inspection 1253435 — Mylan Laboratories Limited (FDF-2)

Mylan Laboratories Limited (FDF-2) — FEI 3008316970

The FDA completed an inspection of Mylan Laboratories Limited (FDF-2) on February 3, 2023 in Chhatrapati Sambhajinagar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 3, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chhatrapati Sambhajinagar (India)

Additional Details

Mutual Recognition Agreement (MRA)